Applied Biosytems, SurroMed Receive $8M NIST Grant | GenomeWeb

SAN FRANCISCO, Oct. 17 – Applied Biosytems and SurroMed jointly received a three-year $8 million grant from the National Institute of Standards and Technology Advanced Technology Program, the companies announced Wednesday.

The grant is for the development of Mountain View, Calif.-based SurroMed's nanoscale technology and Foster City, Calif.-based Applied Biosystems' multiplexing chemistry capabilities for DNA analysis. $3.7 million is slated for SurroMed and $4.3 million for Applied Biosystems, according to the companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.